Modulation of growth factors by growth hormone in children with chronic renal failure

Kidney International

Volumn 51, Issue 6, 1997, Pages 1970-1979

  Powell, David R ^b   Liu, Frances ^b   Baker, Bonita K ^b   Hintz, Raymond L ^b   Lee, Phillip D K ^b   Durham, Susan K ^b   Brewer, Eileen D ^b   Frane, James W ^b   Watkins, Sandra L ^b   Hogg, Ronald J ^a  

^a North Texas Hospital for Children at Medical City   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN;

ANTHROPOMETRY; ARTICLE; BODY GROWTH; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROWTH RETARDATION; HUMAN; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 8244233166     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.268     Document Type: Article

References (47)

1. POWELL DR: Renal disease and growth retardation. The Kidney 22:7-12, 1989
2. ISAAKSON OGP, LINDAHL A, NILSSON A, ISGAARD J: Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocrine Rev 8:426-438, 1987
3. ROBERTS CT, BROWN AL, GRAHAM DE, SEELIG S, BERRY S, GABBAY KH, RECHLER MM: Growth hormone regulates the abundance of IGF-I mRNA in adult rat liver. J Biol Chem 261:10025-10028, 1986
4. COX GN, MCDERMOTT MJ, MERKEL E, STROH CA, KO SC, SQUIRES CH, GLEASON TM, RUSSELL D: Recombinant human insulin-like growth factor (IGF) binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinol 135:1913-1920, 1994
5. VACCARELLO MA, DIAMOND FB, GUEVARA-AGUIRRE J, ROSENBLOOM AL, FIELDER PJ, GARGOSKY SE, COHEN P, WILSON KF, ROSENFELD RG: Hormonal, metabolic and pharmacokinetic effects of recombinant insulin-like growth factor-I in growth hormone receptor deficient (GHRD) syndrome. J Clin Endocrinol Metab 77:273-280, 1993
6. EL-BISHTI M, COUNAHAN R, BLOOM S, CHANTLER C: Hormonal and metabolic responses to intravenous glucose in children on regular hemodialysis. Am J Clin Nutr 31:1865-1869, 1978
7. POWELL DR, ROSENFELD RG, BAKER BK, HINTZ RL: Serum somatomedin levels in adults with chronic renal failure: The importance of measuring insulin-like growth factor (IGF)-I and IGF-II in acid-chromatographed uremic serum. J Clin Endocrinol Metab 63:1186-1192, 1986
8. POWELL DR, ROSENFELD RG, SPERRY JB, BAKER BK, HINTZ RL: Serum concentrations of insulin-like growth factor (IGF)-I, IGF-II and unsaturated somatomedin carrier proteins in children with chronic renal failure. Am J Kidney Dis 10:287-292, 1987
9. PHILLIPS LS, FUSCO AC, UNTERMAN TG, DELGRECO F: Somatomedin inhibitor in uremia. J Clin Endocrinol Metab 59:764-772, 1984
10. BLUM WF, RANKE MB, KIETZMANN K, TONSHOFF B, MEHLS O: Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol 5:539-544, 1991
11. SHIMASAKI S, SHIMONAKA M, ZHANG H-P, LING N: Identification of five different IGFBPs from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem 266:10646-10653, 1991
12. SHIMASAKI S, GAO L, SHIMONAKA M, LING N: Isolation and molecular cloning of insulin-like growth factor binding protein-6. Mol Endocrinol 5:938-948, 1991
13. BAXTER RC, MARTIN JL: Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 78:1504-1512, 1986
14. LEE PDK, HINTZ RL, SPERRY JB, BAXTER RC, POWELL DR: Insulin-like growth factor binding proteins in growth retarded children with chronic renal failure. Pediatr Res 26:308-315, 1990
15. TONSHOFF B, MEHLS O, HEINRICH U, BLUM WF, RANKE MB, SCHAUER A: Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease. J Pediatr 116:561-566, 1990
16. LIU F, POWELL DR, HINTZ RL: Characterization of insulin-like growth factor binding proteins in human serum from patients with chronic renal failure. J Clin Endocrinol Metab 70:620-628, 1990
17. HOKKEN-KOELEGA ACS, STIJNEN T, DE MUINCK KEIZER-SCHRAMA SMPF, WIT JM, WOLFF ED, DEJONG MCJ, DONCKERWOLCKE RA, ABBAD NCB, BOT A, BLUM WF, DROP SLS: Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 338:585-590, 1991
18. LEE PDK, CONOVER CA, POWELL DR: Regulation and function of insulin-like growth factor binding protein-1. Proc Soc Exp Biol Med 104:4-29, 1993
19. BLUM WF, HORN N, KRATZSCH J, JORGENSEN JOL, JUUL A, TEALE D, MOHNIKE K, RANKE MB: Clinical studies of IGFBP-2 by radioimmunoassay. Growth Reg 3:100-104, 1993
20. POWELL DR, LIU F, BAKER B, LEE PDK, BELSHA CW, BREWER ED, HINTZ RL: Characterization of insulin-like growth factor binding protein-3 in chronic renal failure serum. Pediatr Res 33:136-143, 1993
21. KALE AS, LIU F, HINTZ RL, BAKER BK, BREWER ED, LEE PDK, DURHAM SK, POWELL DR: Characterization of insulin-like growth factors (IGFs) and IGF binding proteins in peritoneal dialysate. Pediatr Nephrol 10:467-473, 1996
22. FINE RN: Growth hormone and the kidney: The use of recombinant human growth hormone (rhGH) in growth-retarded children with chronic renal insufficiency. J Am Soc Pediatr Nephrol 1:1136-1145, 1991
23. MEHLS O, TONSHOFF B, BLUM WF, HEINRICH U, SEIDEL C: Growth hormone and insulin-like growth factor I in chronic renal failure pathophysiology and rationale for growth hormone treatment. Acta Pediatr Scand 370(Suppl):28-34, 1990
24. GARGOSKY SE, PHAM HM, WILSON KF, LIU F, GUIDICE LC, ROSENFELD RG: Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: Discrepancies between radioimmunoassay and ligand blotting. Endocrinol 131:3051-3060, 1992
25. CARLSSON LMS, ROWLAND AM, CLARK RG, GESUNDHEIT N, WONG WLT: Ligand-mediated immunofunctional assay for quuntitation of growth hormone binding protein in human blood. J Clin Endocrinol Metab 73:1216-1223, 1991
26. BAXTER RC: Circulating levels and molecular distribution of the acid-labile (α) subunit of high molecular weight insulin-like growth factor binding protein complex. J Clin Endocrinol Metab 70:1347-1353, 1990
27. BAXTER RC, MARTIN JL, BENIAC VA: High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum. J Biol Chem 264:11843-11848, 1989
28. ROSENFELD RG, WILSON DM, LEE PDK, HINTZ RL: Insulin-like growth factors I and II in evaluation of growth retardation. J Pediatr 109:428-433, 1986
29. SCHOENLE E, ZAPF J, HUMBEL RE, FROESCH ER: Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 296: 25225-25230, 1982
30. SCHOENLE E, ZAPF J, HAURI C, STEINER T, FROESCH ER: Comparison of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats. Acta Endocrinol 108:167-174, 1985
31. POWELL DR, ROSENFELD DG, HINTZ RL: Effects of growth hormone therapy and malnutrition on the growth of rats with renal failure. Pediatr Nephrol 2:425-430, 1988
32. POWELL DR, LEE PDK, CHANG D, LIU F, HINTZ RL: Antiserum developed for the E peptide region of insulin-like growth factor-IA prohormone recognizes a serum protein both by immunoblot and by RIA. J Clin Endocrinol Metab 65:868-875, 1987
33. BURCH WM, CORREA J, SHIVELY JE, POWELL DR: The 25 kiloDalton insulin-like growth factor (IGF) binding protein inhibits both basal and IGF-I-mcdiated growth of chick embryo pelvic cartilage in vitro. J Clin Endocrinol Metab 70:173-180, 1990
34. KNAUER DJ, SMITH GL: Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. Proc Natl Acad Sci USA 77:7252-7256, 1980
35. BAXTER RC, MARTIN JL: Binding proteins for the insulin-like growth factors: Structure, regulation and function. Prog Growth Factor Res 1:49-68, 1989
36. DEMELLOW JSM, BAXTER RC: Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 156:199-204, 1988
37. CONOVER CA, RONK M, LOMBANA F, POWELL DR: Structural and biological characterization of bovine insulin-like growth factor binding protein-3. Endocrinol 127:2795-2803, 1990
38. CONOVER CA: Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: Studies of underlying mechanism. Endocrinol 130:3191-3199, 1992
39. TONSHOFF B, BLUM WF, WINGEN A-M, MEHLS O: Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2 and 3 in children with chronic renal failure: Relationship to height and glomerular filtration rate. J Clin Endocrinol Metab 80:2684-2691, 1995
40. KIEFER MC, SCHMID C, WALDVOGEL X, SCHLAPFER I, FUTO E, MASIARZ FR, GREEN K, BARR PJ, ZAPF J: Characterization of recombinant human insulin-like growth factor binding proteins 4, 5 and 6 produced in yeast. J Biol Chem 267:12692-12699, 1992
41. TONSHOFF B, EDEN S, WEISER E, CARLSSON B, ROBINSON ICAF, BLUM WF, MEHLS O: Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma GH binding protein in experimental uremia. Kidney Int 45:1085-1092, 1994
42. JOHANSSON G, SIETNIEKS A, JANSSENS F, PROESMANS W, VANDERSCHUEREN-LODEWEYCKX M, HOLMBERG C, SIPILA I, BROYER M, RAPPAPORT R, ALBERTSSON-WIKLAND K, BERG U, JODAL U, REES L, RIGDEN SPA, PREECE MA: Recombinant human growth hormone treatment in short children with chronic renal disease, before transplantation or with functioning renal transplants: An interim report on five European studies. Acta Pediatr Scand 370(Suppl):36-42, 1990
43. VAN RENEN MJ, HOGG RJ, SWEENEY AL, HENNING PH, PENFOLD JL, JUREIDINI KF: Accelerated growth in short children with chronic renal failure treated with both strict dietary therapy and recombinant growth hormone. Pediatr Nephrol 6:451-458, 1992
44. FINE RN, PYKE-GRIMM K, NELSON PA, BOECHAT MI, LIPPE BM, YADIN O, KAMIl E: Recombinant human growth hormone treatment of children with chronic renal failure: Long-term (1- to 3-year) outcome. Pediatr Nephrol 5:477-481, 1991
45. REES L, RIGDEN SPA, WARD G, PREECE MA: Treatment of short stature in renal disease with recombinant human growth hormone. Arch Dis Child 65:856-860, 1990
46. CONOVER CA, BUTLER PC, WANG M, RIZZA RA, LEE PDK: Lack of growth hormone effect on insulin-associated suppression of insulin-like growth factor binding protein 1 in humans. Diabetes 39:1251-1256, 1990
47. SUWANICHKULA, ALLANDER SV, MORRIS SL, POWELL DR: Glucocorticoids and insulin regulate expression of the human gene for insulin-like growth factor binding protein-1 through proximal promoter elements. J Biol Chem 269:30835-30841, 1994